{
  "id": 20441975,
  "title": "Where is Regeneron headed after record third quarter?",
  "url": "https://urgent.news/2026/11/17/where-is-regeneron-headed-after-record-third-quarter",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-17T14:00:00.000Z",
  "source": {
    "name": "Labiotech",
    "slug": "labiotech",
    "url": "https://www.labiotech.eu/top-pharma-strategy/regeneron-pipeline-2027/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Coming off one of its strongest quarters in years, Regeneron's pipeline has seen approvals, trial fails, and promising readouts. The post Where is Regeneron headed after record third quarter? appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}